Original language | English |
---|---|
Pages (from-to) | 10043-10043 |
Number of pages | 1 |
Journal | Journal of Clinical Oncology |
Volume | 24 |
Issue number | 18 supplement |
DOIs | |
Publication status | Published - 20 Jun 2006 |
Externally published | Yes |
Event | 42nd Annual Meeting of the American-Society-of-Clinical-Oncology - Atlanta, Gabon Duration: 2 Jun 2006 → 6 Jun 2006 |
Phase II trial of iboctadekin (rhIL-18) on a daily X 5 schedule in metastatic melanoma (MM).
J. M. Kirkwood, R. Kefford, T. Logan, P. N. Mainwaring, M. Millward, A. C. Pavlick, M. M. Dar, S. Kathman, K. Laubscher, W. Bell
Research output: Contribution to journal › Meeting abstract › peer-review